Source: Link Testing Instruments Co.,Ltd.
Case Background: A Typical Quality Dispute
A municipal drug testing institute received a commissioned testing task. A local pharmaceutical company (Company A) complained that a batch of pharmaceutical aluminum foil it purchased exhibited abnormalities after filling, suspecting excessive pinholes. However, the aluminum foil manufacturer (Company B) provided a factory inspection report showing that the batch of products was completely qualified. With conflicting accounts, the dispute was submitted to the drug testing institute for an authoritative ruling.
Solution: Building an Authoritative and Reliable Arbitration Testing System
Faced with the dispute, the drug testing institute's responsibility is not only to provide a conclusion on "whether it is qualified or not," but also to ensure that every step of the testing process is traceable, reproducible, and can withstand scrutiny. The core of its solution lies in standardization, rigor, and the integrity of the chain of evidence.
First Stage: Absolute Control and Verification of Testing Conditions
Upon receiving the samples, the drug testing institute did not immediately begin observation but first ensured the compliance of the testing environment.
Environmental Preparation: Testing was conducted in a darkroom, with ambient light intensity strictly calibrated and controlled between 20-50 lux to eliminate stray light interference.
Equipment Status Confirmation: The dedicated pinhole detector is activated, and an illuminance meter is used to verify that the central area illuminance of the transmitted light source remains consistently at 1000 lux, ensuring that the light source conditions fully comply with the YBB00152002-2015 standard.
Sample Processing: Following standard sampling methods, several samples are randomly selected from the disputed batch and equilibrated under standard temperature and humidity conditions to avoid interference from sample deformation or static electricity.
Second Stage: Standardized Double-Blind Observation and Recording Procedure
To eliminate subjective bias, inspectors follow a strict operating procedure:
Systematic Observation: The sample is laid flat on the 400mm x 250mm inspection area of the observation table. Starting from one end, the inspector moves the sample slowly and uniformly, systematically scanning using the light transmission characteristics of pinholes.
Dual Verification: All observations are conducted independently by two experienced inspectors. When one inspector detects a suspected pinhole, the instrument's 100x high-definition magnifying objective is used for localization, and measurements are taken using a ruler with a minimum division of 0.01mm in the eyepiece. The location was then verified by another inspector. This mechanism ensured the objectivity of the test results to the greatest extent possible.
Objective Recording: For each confirmed pinhole, in addition to recording its size, its precise location was marked on the sample diagram, and a high-resolution image was taken as supplementary evidence. All key steps in the entire observation process were recorded.
Third Stage: Data Interpretation and Issuance of Authoritative Reports
After completing the observation, the drug testing institute's work entered the data analysis stage:
Precise Calculation: The total number of pinholes within the specified area was counted, and different size ranges were distinguished (e.g., the number of pinholes larger than 0.3 mm).
Standard Comparison: The calculated results were compared item by item with the limits specified in the YBB standard. In this case, the test found that although the total number of pinholes in the sample did not exceed the limit, there were several pinholes larger than 0.5 mm, which was the key reason for the problem in Company A's production line—smaller pinholes might not affect the operation of its equipment, but larger pinholes directly caused leakage.
Report and Conclusion: The report issued by the drug testing institute not only included the final pass/fail determination, but also detailed the testing environment parameters, equipment status, sampling methods, observation process, and data and images of each representative pinhole. The report clearly pointed out that Company B's factory inspection may have failed to capture locally present large pinholes due to insufficient sampling representativeness or observational oversight.
Extended Value of the Solution: Beyond Single Arbitration
The resolution of this dispute clearly demonstrates the profound value of the drug testing institute's solution:
Unified Technical Standards: Providing the industry with a fair and unified quality evaluation benchmark, resolving technical disputes between companies, and maintaining market order.
Risk Warning and Feedback: The testing data and discovered patterns (such as the distribution characteristics of large pinholes) can provide technical feedback, prompting manufacturers to pay attention to specific process steps and also prompting pharmaceutical companies to adjust their focus in incoming inspection.
Supporting Regulatory and Standard Evolution: The accumulation of a large amount of detailed testing data can provide valuable empirical support for the subsequent revision and improvement of national pharmaceutical packaging material standards.
Conclusion
For pharmaceutical testing institutions, the solution for detecting pinholes in pharmaceutical aluminum foil is essentially a quality evaluation system based on precision instruments, centered on strict standards, and guaranteed by standardized operations. It ensures the scientific validity and authority of test results by translating abstract "compliance requirements" into concrete, verifiable, and reproducible procedures at each step. This system is not only a "judgment standard" for resolving quality disputes but also a crucial technical pillar driving quality awareness across the entire industry chain and ensuring the safety of pharmaceutical products at the point of sale.
For more details please visit www.linktesting.org
